MedPath

IVTCC 2.0: a Prospective Multicenter Ventricular Tachycardia Catheter Ablation Registry

Conditions
Cardiomyopathy
Ventricular Tachycardia
Premature Ventricular Contraction (PVC)
Ventricular Arrhythmia
Registration Number
NCT04520347
Lead Sponsor
University of California, Los Angeles
Brief Summary

This is a prospective multi-center international registry. The objective of this registry is to collect prospective data on patients undergoing catheter ablation for Ventricular Tachycardia (VT) and Premature Ventricular Contractions (PVC). The registry will be used for clinical monitoring, research, and quality improvement purposes.

Detailed Description

Sudden cardiac death (SCD), predominantly due to ventricular tachyarrhythmias, is a leading cause of mortality in the United States and around the world. Catheter ablation of ventricular arrhythmias has proven efficacious in reducing the burden of arrhythmias and reducing implantable cardiac defibrillator (ICD) shocks.

The aim of this study is to create a prospective international database registry that will allow for better assessment of the outcomes of catheter ablation of ventricular arrhythmias. The registry, with approximately 30 participating centers, will help to identify the overall success rates and associated benefits of the procedure and provide more comprehensive data on understudied populations and treatment.

Recruitment & Eligibility

Status
ENROLLING_BY_INVITATION
Sex
All
Target Recruitment
10000
Inclusion Criteria
  • All patients undergoing catheter ablation for ventricular tachycardia (VT) or premature ventricular contractions (PVCs).
Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Ventricular tachycardia (VT) recurrenceFrom date of procedure assessed by shock, Anti-Tachycardia Pacing, or repeat procedure, up to 10 years.

Freedom from ventricular tachycardia episodes requiring ICD Intervention (shock or Anti-Tachycardia Pacing) or repeat procedure.

Secondary Outcome Measures
NameTimeMethod
Rate of complicationsFrom date of procedure assessed up to 12 months.

Cardiovascular-related and procedure-related major complications and/or adverse events.

Time to transplant or deathFrom date of procedure assessed by date of transplant and/or death, up to 10 years.

Trial Locations

Locations (40)

Columbia University Irving Medical Center

๐Ÿ‡บ๐Ÿ‡ธ

New York, New York, United States

Wellspan Health

๐Ÿ‡บ๐Ÿ‡ธ

York, Pennsylvania, United States

Banner Health, University of Arizona Medical Center

๐Ÿ‡บ๐Ÿ‡ธ

Phoenix, Arizona, United States

Cedars-Sinai Medical Center

๐Ÿ‡บ๐Ÿ‡ธ

Los Angeles, California, United States

University of California, Los Angeles

๐Ÿ‡บ๐Ÿ‡ธ

Los Angeles, California, United States

University of California, Davis

๐Ÿ‡บ๐Ÿ‡ธ

Sacramento, California, United States

University of California San Francisco

๐Ÿ‡บ๐Ÿ‡ธ

San Francisco, California, United States

University of Colorado Hospital

๐Ÿ‡บ๐Ÿ‡ธ

Aurora, Colorado, United States

Hartford HealthCare

๐Ÿ‡บ๐Ÿ‡ธ

Hartford, Connecticut, United States

University of Florida Health

๐Ÿ‡บ๐Ÿ‡ธ

Gainesville, Florida, United States

The Kansas City Heart Rhythm Institute

๐Ÿ‡บ๐Ÿ‡ธ

Kansas City, Kansas, United States

University of Maryland Medical Center

๐Ÿ‡บ๐Ÿ‡ธ

Baltimore, Maryland, United States

Johns Hopkins Heart and Vascular Institute

๐Ÿ‡บ๐Ÿ‡ธ

Baltimore, Maryland, United States

Boston Children's Hospital

๐Ÿ‡บ๐Ÿ‡ธ

Boston, Massachusetts, United States

Brigham and Women's Hospital

๐Ÿ‡บ๐Ÿ‡ธ

Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center

๐Ÿ‡บ๐Ÿ‡ธ

Boston, Massachusetts, United States

UMass Memorial Health Care

๐Ÿ‡บ๐Ÿ‡ธ

Worcester, Massachusetts, United States

University of Michigan Frankel Cardiovascular Center

๐Ÿ‡บ๐Ÿ‡ธ

Ann Arbor, Michigan, United States

University of Minnesota VA Medical Center

๐Ÿ‡บ๐Ÿ‡ธ

Minneapolis, Minnesota, United States

Mayo Clinic

๐Ÿ‡บ๐Ÿ‡ธ

Rochester, Minnesota, United States

Washington University in St. Louis

๐Ÿ‡บ๐Ÿ‡ธ

Saint Louis, Missouri, United States

Montefiore Medical Center

๐Ÿ‡บ๐Ÿ‡ธ

Bronx, New York, United States

The Mount Sinai Hospital

๐Ÿ‡บ๐Ÿ‡ธ

New York, New York, United States

Oregon Health & Science University

๐Ÿ‡บ๐Ÿ‡ธ

Portland, Oregon, United States

Children's Hospital of Pennsylvania

๐Ÿ‡บ๐Ÿ‡ธ

Philadelphia, Pennsylvania, United States

University of Pennsylvania Health System

๐Ÿ‡บ๐Ÿ‡ธ

Philadelphia, Pennsylvania, United States

Medical University of South Carolina

๐Ÿ‡บ๐Ÿ‡ธ

Charleston, South Carolina, United States

Vanderbilt Heart and Vascular Institute

๐Ÿ‡บ๐Ÿ‡ธ

Nashville, Tennessee, United States

Texas Cardiac Arrhythmia Institute at St. David's Medical Center

๐Ÿ‡บ๐Ÿ‡ธ

Austin, Texas, United States

Houston Methodist Hospital

๐Ÿ‡บ๐Ÿ‡ธ

Houston, Texas, United States

University of Utah Health

๐Ÿ‡บ๐Ÿ‡ธ

Salt Lake City, Utah, United States

University of Virginia Health System

๐Ÿ‡บ๐Ÿ‡ธ

Charlottesville, Virginia, United States

University of Washington Medical Center

๐Ÿ‡บ๐Ÿ‡ธ

Seattle, Washington, United States

The Montreal Heart Institute

๐Ÿ‡จ๐Ÿ‡ฆ

Montrรฉal, Canada

Shaare Zedek Medical Center

๐Ÿ‡ฎ๐Ÿ‡ฑ

Jerusalem, Israel

Dokkyo Medical University Koshigaya Hospital

๐Ÿ‡ฏ๐Ÿ‡ต

Koshigaya, Japan

Leiden University

๐Ÿ‡ณ๐Ÿ‡ฑ

Leiden, Netherlands

Erasmus Medical Center

๐Ÿ‡ณ๐Ÿ‡ฑ

Rotterdam, Netherlands

Gregorio Maraรฑรณn General University Hospital

๐Ÿ‡ช๐Ÿ‡ธ

Madrid, Spain

St. George's Hospital

๐Ÿ‡ฌ๐Ÿ‡ง

Wandsworth, United Kingdom

ยฉ Copyright 2025. All Rights Reserved by MedPath